Zobrazeno 1 - 6
of 6
pro vyhledávání: '"J H Strijbos"'
Autor:
Hendrika Boezen, Hendricus Groen, J. W. G. van Putten, Z. Erjavec, P. Eppinga, Floris M Wachters, E.G.E. de Vries, G de Leede, Henk Kramer, J H Strijbos
Publikováno v:
British Jounal of Cancer, 89(7), 1192-1199. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer
The purpose of our study was to compare progression-free survival and quality of life (QOL) after cisplatin-gemcitabine (CG) or epirubicin-gemcitabine (EG) in chemotherapy-naive patients with unresectable non-small-cell lung cancer. Patients (n = 240
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c9dfcf9bb8ca6db622c85a7b5470b6c
https://research.rug.nl/en/publications/081c8799-c354-4d65-b0be-d1dda1552665
https://research.rug.nl/en/publications/081c8799-c354-4d65-b0be-d1dda1552665
Autor:
Gysèle S. Bleumink, B H Ch Stricker, S Sanwikarja, J H Strijbos, van Eugène Puijenbroek, M van der Molen-Eijgenraam
Publikováno v:
Clinical Neuropharmacology, 25, 290-293. Lippincott Williams & Wilkins
University of Groningen
CLINICAL NEUROPHARMACOLOGY, 25(5), 290-293. LIPPINCOTT WILLIAMS & WILKINS
University of Groningen
CLINICAL NEUROPHARMACOLOGY, 25(5), 290-293. LIPPINCOTT WILLIAMS & WILKINS
Pleuropulmonary fibrosis is a rare, but well-recognized adverse effect of ergot alkaloids. We report on four patients who developed pleural and/or pulmonary fibrosis during treatment with pergolide and give characteristics of 87 cases with one or mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1e492fb27c4cadfb0ba57d2b92bcb79
https://pubmed.ncbi.nlm.nih.gov/12410064
https://pubmed.ncbi.nlm.nih.gov/12410064
Publikováno v:
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. 55(2)
Rehabilitation in patients with chronic obstructive pulmonary disease (COPD) has been shown to be an effective treatment and can be carried out in different settings, i.e. inpatient, outpatient or home-based. This review focuses on home-based rehabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0bf9ad2a026a999ba3f7795362085a2e
https://pubmed.ncbi.nlm.nih.gov/10949874
https://pubmed.ncbi.nlm.nih.gov/10949874
Autor:
P J, Wijkstra, J H, Strijbos
Publikováno v:
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. 53(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2ce2408f0499370b952af5696c4a4c89
https://pubmed.ncbi.nlm.nih.gov/9828602
https://pubmed.ncbi.nlm.nih.gov/9828602
Publikováno v:
Chest. 109(2)
In this study, the effects of a 12-week hospital-based outpatient pulmonary rehabilitation program (HRP) are compared with those of a 12-week home-care rehabilitation program (HCRP) in COPD patients. A control group received no rehabilitation therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8aa4c47a441feb6487e63cb13aab671f
https://pubmed.ncbi.nlm.nih.gov/8620693
https://pubmed.ncbi.nlm.nih.gov/8620693
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 139(44)
Since 1973, 42 cases of generalized adverse reactions to carbamazepine were reported to the Netherlands Centre for Monitoring of Adverse Reactions to Drugs and the Belgian Centre for Drug Monitoring. The organ involvement can be very diverse in an al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7be93ad9df253b90b7fb1a9da0a23cbd
https://pubmed.ncbi.nlm.nih.gov/7501054
https://pubmed.ncbi.nlm.nih.gov/7501054